India launches 1st batch of indigenous anti-COVID-19 drug
NEW DELHI, May 17 (Xinhua) -- The Indian government Monday launched the first batch of its indigenous anti-COVID-19 drug, 2-deoxy-D-glucose (2-DG).
The drug developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of India's Defence Research and Development Organisation (DRDO) in collaboration with Dr. Reddy's Laboratories (DRL), in the southern city Hyderabad, is used to treat COVID-19 patients.